Aichi, Japan

Toyoharu Numata

This inventor holds 10 USPTO granted patents and 1 published patent application, plus 6 CIPO patents and 5 EPO patents. Top assignees: Raqualia Pharma Inc., Pfizer Corporation, Askat Inc.. Active years: 2009-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Toyoharu Numata. Retrieved from https://idiyas.com/inventor/toyoharu-numata

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 10 

% Patents Active = 70.0

 

 

Average Co-Inventor Count = 4.6

ph-index = 2

Forward Citations = 21(Granted Patents)


Location History:

  • Chita-gun, JP (2009 - 2011)
  • Aichi, JP (2015 - 2019)

Company Filing History:


Years Active: 2009-2026

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Toyoharu Numata: Innovator in Pharmaceutical Chemistry

Introduction

Toyoharu Numata, an accomplished inventor based in Aichi, Japan, has made significant contributions to the field of pharmaceutical chemistry through his innovative patent work. With a remarkable portfolio of five patents, Numata continues to influence the industry with his advancements in polymorph forms and derivative salts.

Latest Patents

Numata's latest inventions include the development of novel crystal forms of 4-{[4-({[4-(2,2,2-trifluoroethoxy)-1,2-benzisoxazol-3-yl]oxy}methyl)piperidin-1-yl]methyl}-tetrahydro-2H-pyran-4-carboxylic acid. This patent explores several polymorph forms—Polymorph Form I, II, III, IV, V, and VI—and details processes for their preparation and uses. Additionally, he has patented various salt forms of this compound, including HCl-salt, HBr-salt, p-toluenesulfonate salt, and ethanedisulfonate salt. His research also includes a method for treating disease conditions mediated by 5-HT4 receptor activity, showcasing the practical application of his inventions in medical treatment.

Career Highlights

Throughout his career, Toyoharu Numata has played pivotal roles in prominent companies such as Raqualia Pharma Inc. and Askat Inc. His innovative mindset and dedication to research have led to breakthroughs that significantly enhance therapeutic options for patients.

Collaborations

Numata has collaborated with esteemed colleagues like Masaki Sudo and Yoshiyuki Okumura, further enriching his research and patent endeavors. These collaborations have contributed to the development of effective pharmaceutical solutions and highlighted the power of teamwork in driving innovation.

Conclusion

Toyoharu Numata stands out as a notable inventor in the realm of pharmaceutical innovations. With his extensive patent portfolio and collaborations, he exemplifies the impact that dedicated inventors can have on the healthcare industry. His work continues to advance our understanding of medicinal compounds and their potential uses in treating various health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…